Editor’s note: Kindara pitched at the RVC Summer Pitchfest in August. At the time of printing they’ve raise a significant amount of their round and intend to close the round in October.
Will Sacks and Kati Bicknell are huge supporters of the science behind the Symptothermal Method of fertility awareness. In fact, they’ve successfully used the method as contraception for the past 3.5 years. However, what started as one couple’s natural, data-based approach to avoiding pregnancy now helps millions of couples do just the opposite: make babies.
Will and Kati are a husband-wife team that founded Kindara, a smartphone tool designed to monitor and educate women about their own fertility. Kindara provides a user-friendly dashboard for inputting morning temperature and other fertility signs, all used to monitor where women are in their menstrual cycles so they can increase (or decrease) their chances of getting pregnant. The tool removes the hassle associated with daily monitoring thus enabling Sympothermal Method adoption and the science behind it.
Now, as a 35 year old, bootstrapping entrepreneur, I myself can get behind the benefit of natural contraception. I’m in no way ready for children. I can also see how Kindara would have been a huge benefit to friends who’ve spent thousands of dollars on fertility treatments. However, my true excitement for this product stems from its public health benefits. Kindara’s hidden beauty is the millions of data points aggregated into what Will and Kati hope will be the world’s largest consumer fertility database. That’s information worthy of the medical industry’s attention.
Anonymous data acquired by Kindara will help identify fertility trends based on age, ethnicity and geographical region. This resource could be pivotal for public health groups attempting to solve recurring fertility issues. For example, Kaiser Permanente has a group dedicated to identifying negative, demographic-based health trends and deriving preventative solutions to address them. To Kaiser, this data enables easier trend identification and quicker preventative action, steps that lead to overall medical cost reductions.
Now, according to Kindara, the fertility test kit market is a $500M/yr and the fertility treatment market is worth $4Bn/yr. These statistics clearly illustrate couples are willing to spend on fertility solutions. Adoption of a less invasive, less expensive alternative will be no exception. Kindara is a solution that A) helps couples avoid confusing, fertility kits that don’t tell a couple anything about their cycle and B) provides a natural option prior to expensive medical intervention.
The Kindara application is free, but advanced services will generate revenues. Users can pay for advice on various fertility products vetted by Kindara’s medical advisors or subscribe for personalized email support from the Kindara support team of fertility counsellors. As of October, Kindara has 15,000+ downloads and 5000+ returning users. The Kindara team is currently accepting seed investment during the month of October to expand and monetize their userbase. If you’re interested in investing or just itching to increase your fertility knowledge base, track down CEO Will Sacks at the Colorado Capital Conference. He’ll be happy to chat.
Contact: Will Sacks (CEO), email@example.com
Funding Round: Seed